Shane Nanayakkara

14PUBLICATIONS
46CO-AUTHORS
Major global burdens of diseaseCardiology (incl. cardiovascular diseases)Respiratory diseasesEpidemiological methodsComputational physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 11, 2026
Type 2 Diabetes in Heart Failure with Preserved and Mildly-Reduced Ejection Fraction: Insights from the REDUCE-LAP-HF II trial.

|Jun 17, 2026
Aortic Stenosis and Heart Failure With Preserved Ejection Fraction: A Cautionary Tale of Common Partners.

|Oct 16, 2025
Insights into pulmonary remodelling in heart failure with preserved ejection fraction through transpulmonary biomarker gradients.

Misha Dagan, Anna L Beale, Bing Wang

|Aug 19, 2025
Withdrawal of heart failure therapy after atrial fibrillation rhythm control with ejection fraction normalization: the WITHDRAW-AF trial.

Louise Segan, Peter M Kistler, Shane Nanayakkara

|May 23, 2024
Ten-Year Risk Equations for Incident Heart Failure in Established Atherosclerotic Cardiovascular Disease Populations.

Luke P Dawson, Melinda J Carrington, Tilahun Haregu

|Jun 23, 2023
New-onset atrial fibrillation prediction: the HARMS2-AF risk score.

Louise Segan, Rodrigo Canovas, Shane Nanayakkara

Pageof 3

Frequent Collaborators

8 joint publications

David M Kaye

3 joint publications

Peter M Kistler

3 joint publications

Dion Stub

2 joint publications

Liang-Han Ling